Optimizing Cleft Care: Le Fort I Osteotomy in Growing vs. Non-Growing Patients

Optimizing Cleft Care: Le Fort I Osteotomy in Growing vs. Non-Growing Patients

Read More
Full Text
last month

Introduction to Surgical Timing in Cleft Management


Managing maxillary hypoplasia in cleft patients requires precision and strategic timing. A recent retrospective study analyzed the effectiveness of the Le Fort I osteotomy across different age groups. Specifically, researchers compared 28 growing patients with 59 non-growing individuals to assess craniofacial morphology changes. Surgeons often debate whether early intervention provides better stability than waiting for skeletal maturity. Consequently, this study offers crucial insights into that decision-making process for multidisciplinary cleft teams.



Clinical Outcomes of Le Fort I Osteotomy


The data revealed that growing patients presented with more severe preoperative conditions. Therefore, this group required significantly larger horizontal advancements of Point A, averaging 6.4 mm compared to 3.2 mm in older patients. Despite these initial differences, both groups achieved similar postoperative cephalometric alignments. Furthermore, the use of miniplates or patient-specific implants provided stable fixation during the procedure. However, practitioners must note that early surgery in growing patients often functions as a two-stage approach. Most of these individuals eventually require a second correction once they reach skeletal maturity.



Comparing Surgical Timing for Maxillary Advancement


Timing remains a critical factor for long-term surgical success. Additionally, the study suggests that severe maxillary hypoplasia does not preclude successful early correction. Therefore, surgeons can achieve significant improvements in facial morphology even in younger cohorts. Nevertheless, practitioners must counsel families regarding the high probability of future revisions. This balanced approach ensures that patients benefit from improved aesthetics and function during their developmental years while preparing for final adulthood alignment. Moreover, customized implants continue to improve the predictability of these complex advancements.



Frequently Asked Questions


Is Le Fort I osteotomy safe for children with clefts?


Yes, the procedure is safe and effective for correcting severe maxillary hypoplasia in growing patients. However, it is often viewed as a temporary correction because further growth may necessitate a second surgery in adulthood.


Why do younger cleft patients need more maxillary advancement?


Younger patients in the Pre-Growth-Completion group often present with more severe skeletal discrepancies. Consequently, they require larger horizontal movements to achieve normal facial proportions compared to patients who have finished growing.



Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.



References



  1. Merta M et al. Cephalometric Comparison of Le Fort I Osteotomy in Growing and Non-Growing Patients With Clefts: A Retrospective Study. Cleft Palate Craniofac J. 2026 Feb 25. doi: 10.1177/10556656261424586. PMID: 41739549.

  2. Alyamani A, Abuzinada S. A protocol used to manage maxillary hypoplasia in cleft lip and palate patients. Open Journal of Stomatology. 2012;2:130-135.

  3. Menon PV. Techniques for the Treatment of Maxillary Hypoplasia in Cleft Patients: An Overview. J Contemp Clin Pract. 2025.

Login to continue

More from MedShots Daily

Optimizing Cleft Care: Le Fort I Osteotomy in Growing vs. Non-Growing Patients
Optimizing Cleft Care: Le Fort I Osteotomy in Growing vs. Non-Growing Patients

Retrospective study compares Le Fort I osteotomy in growing and non-growing cleft patients, noting that younger patients require more maxillary advancement....

last month

Read More
Full Text
Reversible Choroidal Ischemia: A Rare Sight-Threatening Sign of Microscopic Polyangiitis
Reversible Choroidal Ischemia: A Rare Sight-Threatening Sign of Microscopic Polyangiitis

A 53-year-old woman with MPA developed bilateral vision loss due to choroidal ischemia. Prompt immunosuppression led to full visual and partial renal recove...

Today

Read More
Full Text
Pregnancy-Related Death Ratios Post-COVID-19: Analyzing Recovery and Disparities
Pregnancy-Related Death Ratios Post-COVID-19: Analyzing Recovery and Disparities

An analysis of 2018-2024 data shows that while early pregnancy-related deaths have normalized, late postpartum deaths and racial disparities persist....

Today

Read More
Full Text
Polymer Drug Conjugate: A Revolution in Drug Delivery
Polymer Drug Conjugate: A Revolution in Drug Delivery

A comprehensive overview of polymer-drug conjugates, exploring their design, clinical advantages in targeted delivery, and emerging innovations like AI....

Today

Read More
Full Text
Crush Injury Syndrome in Earthquakes: Key Findings for Emergency Response
Crush Injury Syndrome in Earthquakes: Key Findings for Emergency Response

A meta-analysis explores the frequency and complications of crush syndrome in earthquake victims, emphasizing the need for early dialysis and resuscitation....

Today

Read More
Full Text
FSSAI Tightens Bulk Food Labeling Rules: A Major Update
FSSAI Tightens Bulk Food Labeling Rules: A Major Update

FSSAI has mandated strict labeling for bulk food packs starting July 2027, enhancing traceability and nutritional transparency across India's food supply ch...

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris